Literature DB >> 19696477

DNMT3B 579G>T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population.

Haifeng Zhao1, Weiting Du, Dongsheng Gu, Donghai Wang, Feng Xue, Jing Ge, Tao Sui, Renchi Yang.   

Abstract

Epigenetics may influence the expression of numerous genes, which might contribute to autoimmune diseases. DNA methylation is mediated by DNA methyltransferases, especially DNA methyltransferase 3B (DNMT3B). Polymorphisms of the DNMT3B gene may influence DNMT3B activity on DNA methylation and increase the susceptibility to several diseases. The current study investigated the association between DNMT3B 579G>T and the risk for idiopathic thrombocytopenic purpura (ITP). The DNMT3B 579G>T polymorphisms were analyzed by PCR-RFLP. There was no significant difference in genotype and allele distribution between the ITP patient and the controls (p = 0.722 and 0.667, respectively). Similar results were observed between the 2 groups when stratified by age and disease course, including acute in childhood, chronic in childhood, acute in adult and chronic in adult. Importantly, this study showed a statistical difference in the distribution of SNP of DNMT3B between Chinese and Koreans or Americans. It is shown that the SNP of DNMT3B 579G>T may not be used on its own as a marker to predict the susceptibility to ITP in a Chinese population and that DNMT3B 579G>T promoter SNP varies from one ethnic population to another. 2009 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696477     DOI: 10.1159/000235616

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  6 in total

1.  Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts.

Authors:  David A Nielsen; Sara Hamon; Vadim Yuferov; Colin Jackson; Ann Ho; Jurg Ott; Mary Jeanne Kreek
Journal:  Hum Genet       Date:  2010-03-18       Impact factor: 4.132

2.  The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP).

Authors:  Paul A Basciano; James Bussel; Zeeshan Hafeez; Paul J Christos; Paraskevi Giannakakou
Journal:  Br J Haematol       Date:  2012-11-15       Impact factor: 6.998

3.  Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma.

Authors:  Yingbin Lao; Huazhang Wu; Chengchegn Zhao; Qunying Wu; Fengchang Qiao; Hong Fan
Journal:  Biomed Rep       Date:  2013-07-19

4.  DNA-methyltransferase 3B 39179 G > T polymorphism and risk of sporadic colorectal cancer in a subset of Iranian population.

Authors:  Abdolreza Daraei; Rasul Salehi; Faezeh Mohamadhashem
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

Review 5.  DNMT3B Functions: Novel Insights From Human Disease.

Authors:  Miriam Gagliardi; Maria Strazzullo; Maria R Matarazzo
Journal:  Front Cell Dev Biol       Date:  2018-10-22

6.  DNMT3B-579G>T (rs1569686G>T) polymorphism and the risk of multiple sclerosis in a subset of Iranian population.

Authors:  Nasrin Yazdanpanahi; Masoud Etemadifar; Elaheh Shams
Journal:  Iran J Neurol       Date:  2019-04-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.